Carole Ho

CIK 1724605 · Chief Medical Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.97M

Companies

4

Total Filings

78

Lifetime Open-Market Net

-$13.21M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPRX Director 13,103 $54.87 $719.0K $0 2 2026-06-08
DNLI Chief Medical Officer 242,391 $21.66 $5.25M -$13.21M 66 2025-08-14
BEAM Director $29.03 $0 5 2025-06-06
NGM BIOPHARMACEUTICALS INC (NGM) Delisted Director $1.54 $0 5 2024-04-08

Recent Filings · Page 2 of 8

78 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-07 BEAM Grant (A) $0 EDGAR
2024-04-08 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Disp (D) $0 EDGAR
2024-02-15 DNLI Sell (S) −4,189 -$73.1K EDGAR
2024-01-12 DNLI Sell (S) −4,668 -$88.8K EDGAR
2024-01-09 DNLI Sell (S) −9,972 -$193.8K EDGAR
2024-01-05 DNLI Grant (A) +53,720 $0 EDGAR
2023-08-25 DNLI Sell (S) −2,522 -$58.6K EDGAR
2023-08-23 DNLI Sell (S) −2,478 -$56.0K EDGAR
2023-08-16 DNLI Sell (S) −2,768 -$65.9K EDGAR
2023-08-14 DNLI Sell (S) −2,857 -$69.0K EDGAR
Showing 1120 of 78
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.